Opendata, web and dolomites

ENATRANS

Enabling NAnomedicine TRANSlation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ENATRANS" data sheet

The following table provides information about the project.

Coordinator
VDI/VDE INNOVATION + TECHNIK GMBH 

Organization address
address: Steinplatz 1
city: BERLIN
postcode: 10623
website: www.vdivde-it.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.enatrans.eu
 Total cost 1˙999˙406 €
 EC max contribution 1˙999˙406 € (100%)
 Programme 1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
3. H2020-EU.2.3.2.1. (Support for research intensive SMEs)
 Code Call H2020-NMP-CSA-2014
 Funding Scheme CSA
 Starting year 2015
 Duration (year-month-day) from 2015-01-01   to  2017-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VDI/VDE INNOVATION + TECHNIK GMBH DE (BERLIN) coordinator 461˙050.00
2    NANOBIOTIX SA FR (PARIS) participant 408˙250.00
3    ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO PT (GUIMARAES) participant 314˙231.00
4    COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FR (PARIS 15) participant 287˙750.00
5    GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV DE (MUNSTER) participant 233˙125.00
6    TEL AVIV UNIVERSITY IL (TEL AVIV) participant 163˙750.00
7    FONDAZIONE DON CARLO GNOCCHI ONLUS IT (MILANO) participant 131˙250.00

Map

 Project objective

ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts. To be successful SMEs need to understand the requirements of the complex ecosystem made up of regulatory and reimbursement agencies, as well as the requirements of large industrial companies and clinical needs. ENATRANS will gather and provide information about approval processes, regulatory authorities and agencies, clinical and market data, and specific nanomedicine value chain analysis, relevant SME support projects and organisations. ENATRANS will convert this critical information in dedicated learning programs and tools dedicated to translation of nanomedicine. ENATRANS aims at implementing the concept of a Translation Advisory Board (TAB) as central element of the ETPN White Paper. A TAB will be set-up with senior experienced translation experts to guide R&D teams (in SMEs and research institutes) along the translation process to successfully make it to clinical trials and later to the market. Promising projects identified and supported by the TAB need access to clinical centers for first studies in patients, which are able to handle the specificity of new nanotechnology based therapeutics. In addition, financial resources are needed to go pass the regulatory and scale-up processes, which often require funding from investors and/or large companies. ENATRANS will build bridges to clinical trial centers, investors and large companies. Promising projects need guidance to successfully master privileged contacts with the medical, the business or the investment community. ENATRANS will deliver special coaching sessions prior to showcasing of promising projects. Partners in ENATRANS are VDI/VDE-IT, Nanobiotix, CEA, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi, TecMinho.

 Deliverables

List of deliverables.
Minutes of the meetings with industrial unions Documents, reports 2019-05-30 13:33:18
Report 15 press releases Documents, reports 2019-05-30 13:33:18
Nanomedicine Handbook Documents, reports 2019-05-30 13:33:15
5 internships initiated Other 2019-05-30 13:33:17
Updated versions of D5.1 and D5.2 Documents, reports 2019-05-30 13:33:24
6 webinars and 3 recorded Sessions and 5 TAB online advice sessions Other 2019-05-30 13:33:19
Directory of EU clinical centres and CROs with capabilities for nanomedicine testing - early version Documents, reports 2019-05-30 11:28:49
Compendium describing the regulatory and approval issues along the translation process including the involved agencies Documents, reports 2019-05-30 11:28:49
Recommendation report on most relevant unmet clinical needs potentially profiting from nanotechnologies - early version Documents, reports 2019-05-30 11:29:01
Compendium of communication material for use as promotional material on events Documents, reports 2019-05-30 11:29:03
Web based data bank with names and contact data of all relevant agencies to be contacted during translation Websites, patent fillings, videos etc. 2019-05-30 11:29:03
One session per year dedicated to the ecosystem at the annual project at a relevant meeting Other 2019-05-30 11:28:49

Take a look to the deliverables list in detail:  detailed list of ENATRANS deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ENATRANS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ENATRANS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.2.2.;H2020-EU.2.1.2.;H2020-EU.2.3.2.1.)

ENATRANS (2015)

Enabling NAnomedicine TRANSlation

Read More